Vcanbio Cell & Gene Engineering Corp., Ltd Stock
Equities
600645
CNE000000545
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
18.56 CNY | +0.71% | -8.03% | -8.44% |
Sales 2022 | 1.55B 215M | Sales 2023 | 1.59B 220M | Capitalization | 9.49B 1.31B |
---|---|---|---|---|---|
Net income 2022 | 113M 15.64M | Net income 2023 | 106M 14.68M | EV / Sales 2022 | 4.31 x |
Net cash position 2022 | 1.25B 173M | Net cash position 2023 | 1.45B 201M | EV / Sales 2023 | 5.05 x |
P/E ratio 2022 |
70.9
x | P/E ratio 2023 |
88.1
x | Employees | 2,209 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 71.64% |
1 day | +0.71% | ||
1 week | -8.03% | ||
Current month | +4.27% | ||
1 month | +19.28% | ||
3 months | +17.69% | ||
6 months | -8.71% | ||
Current year | -8.44% |
Managers | Title | Age | Since |
---|---|---|---|
Yong Wang
CEO | Chief Executive Officer | 57 | 09-06-29 |
Xiao Ting Wang
DFI | Director of Finance/CFO | 42 | 22-05-24 |
Hai Bin Li
BRD | Director/Board Member | 53 | 16-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hong Jia Gong
CHM | Chairman | 59 | 22-03-25 |
Yong Wang
CEO | Chief Executive Officer | 57 | 09-06-29 |
Xin Yi Hou
BRD | Director/Board Member | 64 | 20-05-18 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.87% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 18.56 | +0.71% | 8,778,650 |
24-05-16 | 18.43 | -1.60% | 11,002,800 |
24-05-15 | 18.73 | +0.21% | 13,563,440 |
24-05-14 | 18.69 | -2.10% | 20,448,900 |
24-05-13 | 19.09 | -5.40% | 34,511,960 |
End-of-day quote Shanghai S.E., May 16, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-8.44% | 1.19B | |
-4.67% | 12.32B | |
-5.19% | 8.07B | |
+9.45% | 5.91B | |
+28.50% | 5.52B | |
-8.09% | 4.21B | |
-55.31% | 2.99B | |
+13.49% | 2.73B | |
-1.34% | 2.43B | |
+32.24% | 2.29B |
- Stock Market
- Equities
- 600645 Stock